Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

The vector that got away

Nature Biotechnology volume 22, page 379 (2004)Cite this article

To the editor:

Your editorial in the January issue (Nat. Biotechnol. 22, 1, 2004) rightly raises concerns over the regulatory oversight of the GloFish marketed in the United States by Yorktown Technologies (Austin, TX, USA). But the most pertinent question is what exactly is the transgenic content of this animal?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. US Food and Drug Administration. FDA Statement Regarding GloFish. (USFDA, Rockville, MD) (December 9, 2003). http://www.fda.gov/bbs/topics/NEWS/2003/NEW00994.html

Download references

Author information

Authors and Affiliations

  1. Rosenstiel School of Marine and Atmospheric Sciences, University of Miami, Miami, 33149, Florida, USA

    Pat Gibbs

Authors
  1. Pat Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gibbs, P. The vector that got away. Nat Biotechnol 22, 379 (2004). https://doi.org/10.1038/nbt0404-379a

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0404-379a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing